Traumatic brain injuries: structural changes J Cervos-Navarro, JV Lafuente Journal of the neurological sciences 103, 3-14, 1991 | 150 | 1991 |
El diseño curricular por competencias en educación médica: impacto en la formación profesional JV Lafuente, JF Escanero, JM Manso, S Mora, T Miranda, M Castillo, ... Educación médica 10 (2), 86-92, 2007 | 147 | 2007 |
Nϵ-Carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease X Gironès, A Guimerà, CZ Cruz-Sánchez, A Ortega, N Sasaki, Z Makita, ... Free Radical Biology and Medicine 36 (10), 1241-1247, 2004 | 119 | 2004 |
Estilos de aprendizaje de estudiantes de medicina en universidades latinoamericanas y españolas: relación con los contextos geográficos y curriculares G Díaz-Véliz, S Mora, JV Lafuente-Sánchez, PA Gargiulo, R Bianchi, ... Educación médica 12 (3), 183-194, 2009 | 96 | 2009 |
Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-β (PDGFR-β) in human gliomas JV Lafuente, B Adan, K Alkiza, JM Garibi, M Rossi, FF Cruz-Sanchez Journal of Molecular Neuroscience 13, 177-185, 1999 | 88 | 1999 |
Increased antiparkinson efficacy of the combined administration of VEGF-and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease E Herran, C Requejo, JA Ruiz-Ortega, A Aristieta, M Igartua, ... International Journal of Nanomedicine, 2677-2687, 2014 | 87 | 2014 |
Intranasal administration of chitosan-coated nanostructured lipid carriers loaded with GDNF improves behavioral and histological recovery in a partial lesion model of Parkinson … O Gartziandia, E Herrán, JA Ruiz-Ortega, C Miguelez, M Igartua, ... Journal of biomedical nanotechnology 12 (12), 2220-2280, 2016 | 86 | 2016 |
Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: the role of glia and NRf2 regulation S Hernando, C Requejo, E Herran, JA Ruiz-Ortega, T Morera-Herreras, ... Neurobiology of Disease 121, 252-262, 2019 | 83 | 2019 |
In vivo administration of VEGF-and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson’s disease E Herran, JÁ Ruiz-Ortega, A Aristieta, M Igartua, C Requejo, JV Lafuente, ... European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 1183-1190, 2013 | 83 | 2013 |
Effects of visual experience on vascular endothelial growth factor expression during the postnatal development of the rat visual cortex H Bengoetxea, EG Argandoña, JV Lafuente Cerebral Cortex 18 (7), 1630-1639, 2008 | 73 | 2008 |
Enriched and deprived sensory experience induces structural changes and rewires connectivity during the postnatal development of the brain H Bengoetxea, N Ortuzar, S Bulnes, I Rico-Barrio, JV Lafuente, ... Neural plasticity 2012 (1), 305693, 2012 | 72 | 2012 |
VEGFR-2 expression in brain injury: its distribution related to brain–blood barrier markers JV Lafuente, EG Argandona, B Mitre Journal of neural transmission 113, 487-496, 2006 | 70 | 2006 |
Effects of dark-rearing on the vascularization of the developmental rat visual cortex EG Argandona, JV Lafuente Brain research 732 (1-2), 43-51, 1996 | 67 | 1996 |
Oxidative stress in Alzheimer's disease hippocampus: a topographical study FF Cruz-Sánchez, X Girones, A Ortega, F Alameda, JV Lafuente Journal of the neurological sciences 299 (1-2), 163-167, 2010 | 63 | 2010 |
Influence of visual experience deprivation on the postnatal development of the microvascular bed in layer IV of the rat visual cortex EG Argandoña, JV Lafuente Brain research 855 (1), 137-142, 2000 | 58 | 2000 |
Blood-brain barrier changes in high altitude J V Lafuente, G Bermudez, L Camargo-Arce, S Bulnes CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016 | 55 | 2016 |
Silicon dioxide nanoparticles (SiO2, 40–50 nm) exacerbate pathophysiology of traumatic spinal cord injury and deteriorate functional outcome in the rat. An experimental study … HS Sharma, R Patnaik, A Sharma, PO Sjöquist, JV Lafuente Journal of Nanoscience and Nanotechnology 9 (8), 4970-4980, 2009 | 53 | 2009 |
Nanowired drug delivery across the blood-brain barrier in central nervous system injury and repair A Sharma, P Menon, D F Muresanu, A Ozkizilcik, Z Ryan Tian, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016 | 50 | 2016 |
Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats LH Llano Lopez, F Caif, S García, M Fraile, AI Landa, G Baiardi, ... Pharmacological reports 64 (1), 54-63, 2012 | 50 | 2012 |
Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine HS Sharma, DF Muresanu, A Nozari, JV Lafuente, ZR Tian, S Sahib, ... International review of neurobiology 151, 1-66, 2020 | 48 | 2020 |